December 22, 2014 3:03 PM ET

Healthcare Equipment and Supplies

Company Overview of Greystone Pharmaceuticals, Inc.

Company Overview

Greystone Pharmaceuticals, Inc. develops wound care technologies. The company offers Epi-Max, an acetylated regenerated cellulose sterile dressing for chronic wounds for customers in the United States; Matrix metalloproteinase, a zinc-dependent protein that propagate in tissue after it becomes damaged or, in some cases, after the tissue is afflicted by disease; and DerMax, a Class IIa medical device in the EU. It sells Matrix metalloproteinases through distributors in Europe and the Middle East. The company offers Epi-Max for use as a wound dressing to manage diabetic ulcers, decubitus ulcers, leg ulcers, and acute severe wounds. Its technologies improves quality of life and healthcare outco...

16261 Bass Road

Suite 202

Fort Myers, FL 33908

United States

Founded in 1996

Phone:

239-432-2780

Fax:

239-432-2782

Key Executives for Greystone Pharmaceuticals, Inc.

Chief Financial Officer
Managing Director of Dermagenics-Europe
Chief Medical Officer
Director of Sales and Marketing - Dermagenics Europe
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Otto Bock HealthCare LLP United States
Occupational Marketing, Inc. United States
First Quality Products, Inc. United States
Human Touch, LLC United States
Otothera Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Greystone Pharmaceuticals, Inc., please visit www.greystonepharmaceuticals.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.